The goal of this Randomized controlled trial is to evaluate in household ambulatory, elderly patients sustaining femoral neck fracture who are subjected to be treat with cementless bipolar hemiarthroplasty. The main questions it aims to answer are:
* The efficacy in reducing blood transfusion for topical tranexamic acid administration * The safety of tranexemic acid, topically used
As having undergone bipolar hemiarthroplasty surgery, participants will either receive retrograde intraarticular tranexamic acid injection via drain tube, or topical soaking administration.
Researchers will compare, with standard procedure (procedure), whether topically administered tranexamic acid would reduce rate of blood transfusion.
Elderly patients (age > 60 years)
Femoral neck fractures from low energy mechanism
Household ambulator
Undergoing cementless bipolar hemiarthroplasty at KCMH
Allergy to TXA
History of VTE
History of hip surgery, pathological fracture, hip infection
Congenital or acquired coagulopathy
Parallel
Retrograde Intraarticular Injection via Drain Tube
DrugTranexamic acid will be injected via drain tube after wound closure
Topical Soaking of Tranexamic Acid
DrugTranexamic acid will be topically administered by soaking method
Placebo Comparator: Standard procedure (placebo)
DrugStandard wound management
Rate of blood transfusion
Proportion of patients received blood transfusion divided by total number of patient in a group
Volume of blood transfusion
total volume of blood transfusion per each patient
Calculated blood loss
Calculating using Nadler and Goss formula
Any adverse events
Adverse events include wound complication, deep vein thrombosis, pulmonary embolism, and other complication
In-hospital mortality
In-hospital mortality
Click on the lead sponsor to view all of their trials.
